Pilulka Lekarny As Stock Probability Of Bankruptcy

PINK Stock  CZK 142.00  7.00  5.19%   
Pilulka Lekarny's likelihood of distress is under 9% at this time. It has tiny risk of undergoing some form of financial crisis in the near future. Pilulka Lekarny's Probability of distress is determined by interpolating and adjusting Pilulka Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Pilulka balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pilulka Lekarny as. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pilulka Lekarny as Company probability of distress Analysis

Pilulka Lekarny's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy




More About Probability Of Bankruptcy | All Equity Analysis

Current Pilulka Lekarny Probability Of Bankruptcy

  Less than 9%  
Most of Pilulka Lekarny's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pilulka Lekarny as is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Pilulka Lekarny probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Pilulka Lekarny odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Pilulka Lekarny as financial health.
Please note, there is a significant difference between Pilulka Lekarny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pilulka Lekarny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pilulka Lekarny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Based on the latest financial disclosure, Pilulka Lekarny as has a Probability Of Bankruptcy of 9.0%. This is 79.21% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The probability of bankruptcy for all Czech Republic stocks is 77.4% higher than that of the company.

Pilulka Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pilulka Lekarny's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pilulka Lekarny could also be used in its relative valuation, which is a method of valuing Pilulka Lekarny by comparing valuation metrics of similar companies.
Pilulka Lekarny is currently under evaluation in probability of bankruptcy category among its peers.

Pilulka Fundamentals

About Pilulka Lekarny Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pilulka Lekarny as's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pilulka Lekarny using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pilulka Lekarny as based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Tools for Pilulka Stock Analysis

When running Pilulka Lekarny's price analysis, check to measure Pilulka Lekarny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pilulka Lekarny is operating at the current time. Most of Pilulka Lekarny's value examination focuses on studying past and present price action to predict the probability of Pilulka Lekarny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pilulka Lekarny's price. Additionally, you may evaluate how the addition of Pilulka Lekarny to your portfolios can decrease your overall portfolio volatility.